3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Breast Diseases
1
Interventions
abemaciclib
2
Fulvestrant
2
trastuzumab deruxtecan
1
taxane
1
ribociclib
1
pertuzumab
1
palbociclib
1
exemestane
1
elacestrant
1
Trastuzumab
1
Tamoxifen
1
STX-478
1
RAD1901
1
Metformin
1
Letrozole
1
Imlunestrant
1
Genotype
1
Body Height
1
Blood Pressure
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Diseases
×
Body Height
×
30 days
×
Clear all
NCT05006196
2026-05-20
IMOGEN
Perspectum
Active not recruiting
1,030 enrolled